The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 06, 2018
Filed:
Oct. 15, 2015
Applicant:
Almirall, S.a., Barcelona, ES;
Inventors:
Fritjof Evers, Reinbek, DE;
Henning Mallwitz, Buchholz/N., DE;
Ricarda Wessel, Neumarkt, DE;
Christoph Willers, Hamburg, DE;
Assignee:
ALMIRALL, S.A., Barcelona, ES;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/58 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 31/58 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01);
Abstract
Topical pharmaceutical compositions are described comprising, based on the total weight of the composition: a) 0.01 to 0.2 wt. % of mometasone furoate, b) 5 to 18 wt. % of hexylene glycol, c) 20 to 40 wt. % of water, and d) 25 to 70 wt. % of an oil phase. Said compositions are stable and can be safely and easily applied over large surface areas of the skin in an acceptable way by the general patient population for the treatment or prevention of psoriasis, atopic dermatitis (atopic eczema) and other skin disorders or diseases.